We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,038.00
Bid: 12,040.00
Ask: 12,042.00
Change: -118.00 (-0.97%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Cantor Upgrades easyJet To Buy From Hold

Tue, 09th Aug 2016 08:33

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning and Monday:
----------
FTSE 100
----------
CANTOR FITZGERALD RAISES EASYJET TO 'BUY' ('HOLD') - TARGET 1300 PENCE
----------
TRADERS: MACQUARIE CUTS AVIVA TO 'NEUTRAL' ('OUTPERFORM')
----------
GOLDMAN CUTS AVIVA PRICE TARGET TO 480 (485) PENCE - 'BUY'
----------
BERENBERG RAISES RSA INSURANCE PRICE TARGET TO 501 (448) PENCE - 'HOLD'
----------
CITIGROUP REVISES STANDARD CHARTERED PRICE TARGET TO 750 PENCE - 'BUY'
----------
GOLDMAN RAISES STANDARD CHARTERED PRICE TARGET TO 760 (740) PENCE - 'BUY'
----------
CITIGROUP RAISES HSBC PRICE TARGET TO 600 (515) PENCE - 'BUY'
----------
GOLDMAN RAISES RBS PRICE TARGET TO 240 (235) PENCE - 'BUY'
----------
GOLDMAN CUTS LLOYDS PRICE TARGET TO 53 (55) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BARCLAYS PRICE TARGET TO 175 (170) PENCE - 'NEUTRAL'
----------
TRADERS: NUMIS CUTS INFORMA TO 'ADD' ('BUY')
----------
RBC RAISES ANTOFAGASTA PRICE TARGET TO 500 (410) PENCE - 'SECTOR PERFORM'
----------
DEUTSCHE BANK RAISES BUNZL PRICE TARGET TO 2520 (2100) PENCE - 'BUY'
----------
JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 4900 (4800) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES RELX PRICE TARGET TO 1370 (1210) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
LIBERUM CUTS SERCO GROUP TO 'HOLD' ('BUY') - TARGET 135 (120) PENCE
----------
RBC RAISES INDIVIOR PRICE TARGET TO 325 (185) PENCE - 'SECTOR PERFORM'
----------
GOLDMAN RAISES WILLIAM HILL PRICE TARGET TO 320 (310) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS WILLIAM HILL PRICE TARGET TO 390 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES LADBROKES PRICE TARGET TO 148 (136) PENCE - 'HOLD'
----------
SHORE CAPITAL RAISES OCADO TO 'HOLD' ('SELL')
----------
JPMORGAN CUTS JLT GROUP PRICE TARGET TO 850 (1020) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES MEGGITT PRICE TARGET TO 445 (395) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES JD WETHERSPOON PRICE TARGET TO 980 (840) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES RENTOKIL INITIAL PT TO 235 (225) PENCE - 'OUTPERFORM'
----------
TRADERS: MACQUARIE RAISES PARAGON GROUP TO 'OUTPERFORM' ('NEUTRAL')
----------
GOLDMAN RAISES VEDANTA RESOURCES PRICE TARGET TO 440 (425) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES METRO BANK PRICE TARGET TO 1630 (1560) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BBA AVIATION PRICE TARGET TO 285 (186) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
LIBERUM RAISES BOOHOO PRICE TARGET TO 90 (80) PENCE - 'BUY'
----------
TRADERS: NUMIS RAISES SDL TO 'ADD' ('HOLD')
----------
TRADERS: NUMIS RAISES DEVRO TO 'BUY' ('ADD')
----------
BERENBERG CUTS MOTHERCARE PRICE TARGET TO 100 (130) PENCE - 'SELL'
----------
BERENBERG CUTS CARPETRIGHT PRICE TARGET TO 230 (450) PENCE - 'HOLD'
----------
BERENBERG CUTS TOPPS TILES PRICE TARGET TO 125 (155) PENCE - 'HOLD'
----------
PANMURE RAISES GEMFIELDS RESOURCES PRICE TARGET TO 61 (57) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.